DeepNiche

CRISPR in the clinic

Highest CTX310 dose cuts ANGPTL3 78.6 percent at year one

Among the 4 participants who received the highest dose (0.8 mg/kg), the mean percent change from baseline at 1 year was -78.6% in ANGPTL3, -52.5% in LDL cholesterol, and -47.8% in triglycerides.

source: hcplive.com

Get DeepNiche

The full briefing is in the app.

More CRISPR in the clinic clippings